Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ExoLab Italia has commercialized plant-derived exosome ingredients in the nutraceutical and cosmetic markets through partnerships with Guna spa and Arkana Cosmetics. The company is also collaborating with Dompè Farmaceutici on pharmaceutical development projects. Their technology enhances bioavailability and absorption of active compounds. No clinical trial results are published yet for pharma applications; current pharma work appears to be pre-clinical or early-stage research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ExoLab Italia.